Close
 Indian J Med Microbiol  
 

Figure 2 (A-C): Pre-RFA evaluation. CE-US (A) shows the enhancing liver nodule (arrow) in the arterial phase. The contrast dynamics software shows analysis of the peak enhancement of the HCC nodule -97.7% (B) at 15 seconds compared tonormal liver enhancement pattern with peak enhancement of the normal liver of 64.7% (C)

Figure 2 (A-C): Pre-RFA evaluation. CE-US (A) shows the enhancing liver nodule (arrow) in the arterial phase. The contrast dynamics software shows analysis of the peak enhancement of the HCC nodule -97.7% (B) at 15 seconds compared tonormal liver enhancement pattern with peak enhancement of the normal liver of 64.7% (C)